References
- Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064-1073.
- Mah MW, Memish Z. Antibiotic resistance: An impending crisis. Saudi Med J 2000; 21: 1125-1129.
- Shibl AM, Tawfik AF, Khan AM, Qadri SMH, Ramadan MA. Prevalence of methicillin-resistant staphylococci and susceptibility to antimicrobial agents in Riyadh, Saudi Arabia. Curr Therapeut Res 1994; 55: 76-82.
- Orden B, Perez-Trallero E, Montes M, Martinez R. Erythromycin resistance of S. pyogenes in Madrid. Ped Infect Dis J 1998; 17: 470-473.
- Felmingham D, Gruneberg RN and the Alexander Project Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993. The Alexander Project. J Antimicrob Chemother 1996; 38, (Suppl. A): 1-57.
- Shibl AM, Al Rasheed AM, Elbashier AM, Osoba AO. Penicillin-resistant and intermediate S. pneumoniae in Saudi Arabia. J Chemother 2000; 12, (2): 134-137.>
- Lectercg R. Epidemiology and control of multi-resistant enterococci. Drug 1996; 52: 47-49.
- Kunin CM. Resistance to antimicrobial drugs: A worldwide calamity. Ann Intern Med 1993; 118: 557-561.
- Michel M Gutmann L. Methicillin-resistant S. aureus and vancomycin resistant enterococci. Therapeutic realities and possibilities. Lancet 1997; 349: 1901-1906.
- Ismael NA. Clinical isolates of enterococci with high level resistance to currently available aminoglycosides. J Hosp Infect 1992; 20: 35-42.
- Shibl AM. Incidence of B-lactamase production among outpatient clinical isolates in Middle Eastern Countries and their antibiotic susceptibilities. Chemotherapy 1992; 38: 324-329.
- Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and E. coli in nursing homes. JAMA 1999; 281: 517-523.
- El-Karsh T, Tawfik AF, Al-Shammary F, Alsalah S, Kambal AM, Shibl AM. Antimicrobial resistance and prevalence of extended spectrum beta-lactamse among clinical isolates of Gram-negative bacteria in Riyadh. J Chemother 1995; 7: 509-514.
- Peltola H. Worldwide H. influenzae type b disease at the beginning of the 21st Century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13: 302-317.
- Barden LS, Powel SF, Schwartz B, Lackey C. Current attitudes regarding use of antimicrobial agents: results from physician’s and parent’s focus group discussions. Clin Pediatr 1998; 37: 665-672.
- House of Lords Select Committee on Science and Technology. Seventh report. London. Stationery office. 1998.
- Schwarts BH, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials and patients. JAMA 1997; 278: 944-945.
- Elliot VS. FDA calls for changes in drug labeling. Am Med News 2001; 22: 1-3.